Dimensional Fund Advisors
NMTR

Dimensional Fund Advisors’s 9 Meters Biopharma NMTR Stock Holding History

Dimensional Fund Advisors’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16,264
Closed -$22.6K – 3541
2023
Q1 		$22.6K Sell
16,264
-255
-2% -$481 ﹤0.01% 3432
2022
Q4 		$21 Buy
+16,519
New +$37.7K ﹤0.01% 3458

Other funds holding NMTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
CIBC Asset Management
CIBC Asset Management Toronto, Ontario, Canada $40.9B AUM 35.96% 1-Year Est. Return

Dimensional Fund Advisors's NMTR Position: Q2 2023 in Review

Dimensional Fund Advisors sold out of 9 Meters Biopharma (NMTR) in Q2 2023, closing a stake of 16,264 shares — an estimated $22.6K sold.

Dimensional Fund Advisors first reported a position in NMTR in Q4 2022 and held it in 2 quarters. The position peaked at $22.6K in Q1 2023. 34 funds tracked by Wall St. Rank hold NMTR as of Q2 2023.

  • Dimensional Fund Advisors reported no remaining 9 Meters Biopharma position as of Q2 2023 after selling out during the quarter.
  • Dimensional Fund Advisors sold 16,264 9 Meters Biopharma shares in Q2 2023, an estimated $22.6K.
  • Dimensional Fund Advisors first reported a position in 9 Meters Biopharma in Q4 2022 and held it in 2 quarters.
  • Dimensional Fund Advisors's 9 Meters Biopharma position peaked at $22.6K in Q1 2023.
  • 34 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q2 2023.

Based on Dimensional Fund Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.